8-Bromo-4-chloroquinazoline

Catalog No. :
ACFEOP098
CAS No. :
125096-72-2
Molecular Formula :
C8H4BrClN2
Molecular Weight :
243.49

IUPAC Name:8-bromo-4-chloroquinazoline

8-Bromo-4-chloroquinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$68.00Login to see priceIn stockInquiry
5g97%$319.00Login to see priceIn stockIn stock
10g97%$538.00Login to see priceIn stockIn stock
25g97%$1062.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Bromo-4-chloroquinazoline
IUPAC Name8-bromo-4-chloroquinazoline
MDL No.MFCD09738589
Molecular FormulaC8H4BrClN2
Molecular Weight243.49
SMILESClC1=C2C=CC=C(Br)C2=NC=N1
InChI KeyNVMDCMMESVPNHN-UHFFFAOYSA-N
SynonymA15181 | 4-CHLORO-8-BROMOQUINAZOLINE | DS-10779 | MFCD09738589 | BCP26709 | CS-D0030 | FT-0646883 | Z316120010 | DTXSID90559799 | EN300-42989 | SCHEMBL856304 | SY019484 | AKOS000147824 | AM20060871 | 8-bromo-4-chloroquinazoline | 8-bromo-4-chloro-quinazol
CAS No.125096-72-2
PubChem CID14397530

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACFEOP098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRFUQ981 route compound structure diagram
    ACRFUQ98177150-35-7 In Stock
  4. Then
  5. ACFEOP098 route product structure diagram
    ACFEOP098125096-72-2 In Stock
Inquiry

2. ACFEOP098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACFEOP098 route compound structure diagram
    ACFEOP098125096-72-2 In Stock
  4. Then
  5. ACFEOP098 route product structure diagram
    ACFEOP098125096-72-2 In Stock
Inquiry

Comments (0)